Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,898.00 GBX | +0.35% | -3.33% | +12.25% |
Sep. 18 | European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August | MT |
Sep. 18 | AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
183.54 | +17.22% | 20 | |||||||
995.42 | +9.99% | 25 | |||||||
967.54 | +9.67% | 26 | |||||||
171.32 | +3.11% | 22 | |||||||
196.30 | +1.74% | 27 | |||||||
139.03 | +17.18% | 26 | |||||||
301.11 | +12.19% | 19 | |||||||
116.69 | +0.65% | 20 | |||||||
324.71 | -2.47% | 24 | |||||||
33.61 | +12.97% | 22 | |||||||
112.40 | +9.17% | 22 | |||||||
83.54 | -0.42% | 27 | |||||||
53.34 | +7.24% | 21 | |||||||
19.70 | +22.81% | 21 | |||||||
6,663.33 | -1.34% | 15 | |||||||
6,541.18 | +33.63% | 17 | |||||||
3.865 | -2.59% | 17 | |||||||
4,768.83 | +13.35% | 18 | |||||||
58.20 | +28.98% | 15 | |||||||
Average | 1,143.88 | +10.16% | 21 | ||||||
Weighted average by Cap. | 702.42 | +8.91% | 23 |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus